688331.SH
荣昌生物
SSE · Healthcare · Biotechnology · CN
CNY 116.42
−7.24%Margins
Gross margin
86.9%
EBITDA margin
29.1%
EBIT margin
38.5%
Net margin
38.2%
FCF margin
1.3%
32.9%
Return on equity
17.5%
Return on assets
22.6%
Return on invested capital
0.46x
Asset turnover
CNY 252.6M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026